Publications by authors named "E Bramucci"
Aims: The PROMUS™ Element™ European Post-Approval Surveillance Study (PE-Prove) is a prospective, open-label, multicentre observational study designed to assess outcomes following PROMUS Element everolimus-eluting stent implantation in an unselected patient population.
Methods And Results: A total of 1,010 patients were enrolled at 40 clinical sites in Europe, including 24.9% with medically treated diabetes, 50.
Coronary plaque ulceration documented at sequential angiography and confirmed by optical coherence tomography in a patient with recurrent acute coronary syndrome.
J Cardiovasc Med (Hagerstown)
December 2016
: A 51-year-old man was hospitalized for recurrence of acute coronary syndrome after few months. Coronary angiography during first hospitalization showed no significant coronary stenosis, while the second time, right coronary artery presented an expansion at the proximal segment. Optical coherence tomography documented a long fibroatheroma with an ulceration and residual white thrombus.
View Article and Find Full Text PDFArticle Synopsis
- Optimal antiplatelet therapy for patients with coronary stents undergoing surgery is still unclear and debated among healthcare professionals due to the risk of complications like stent thrombosis.
- Current clinical guidelines lack specific recommendations for managing antiplatelet therapy during high-risk surgeries, highlighting the need for better-defined ischaemic and haemorrhagic risk categories.
- A new consensus document offers practical recommendations, suggesting the continuation of aspirin during most surgeries and careful management of dual antiplatelet therapy, including the possible use of short-acting intravenous treatments for high-risk patients.